antigen binding Applications
-
Medical solutions for vaccine platform sector
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. The particle capsid surface has repetitive, immunogenic sites, where peptides of interest can be inserted and allows us to generate monovalent or bivalent vaccines as required. Each peptide of interest will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are activated to ...
By 2A Pharma ApS based in Aalborg Øst, DENMARK.
-
Antibody Discovery
The antibody drug discovery process differs from the traditional drug discovery of small molecules as it requires the development of hybridomas and the engineering of antibodies to recognize a specific target protein. The production of recombinant antibodies in cancer treatment as well as the development of neutralizing antibodies for infectious diseases, has allowed antibody discovery platforms to interrogate the immune repertoire and develop novel antibody libraries using flow cytometry analysis and cell ...
By NanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you